LEO, MARENZA
 Distribuzione geografica
Continente #
NA - Nord America 2.126
EU - Europa 861
AS - Asia 245
AF - Africa 60
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.302
Nazione #
US - Stati Uniti d'America 2.082
SE - Svezia 282
IT - Italia 178
CN - Cina 142
BG - Bulgaria 92
DE - Germania 88
GB - Regno Unito 69
AT - Austria 42
CA - Canada 42
FR - Francia 41
CI - Costa d'Avorio 38
VN - Vietnam 30
SG - Singapore 25
FI - Finlandia 20
SN - Senegal 20
IN - India 17
UA - Ucraina 16
TR - Turchia 15
BE - Belgio 11
RU - Federazione Russa 11
HK - Hong Kong 10
NL - Olanda 4
AU - Australia 3
EU - Europa 3
SA - Arabia Saudita 3
BR - Brasile 2
CH - Svizzera 2
PA - Panama 2
RO - Romania 2
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
JP - Giappone 1
PK - Pakistan 1
PL - Polonia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.302
Città #
Fairfield 288
Woodbridge 286
Houston 263
Ann Arbor 234
Chandler 158
Ashburn 138
Seattle 132
Wilmington 103
Sofia 92
Cambridge 85
Serra 66
New York 56
Beijing 52
Vienna 41
Abidjan 38
Ottawa 37
Princeton 37
London 32
Lawrence 31
Medford 29
Bremen 26
Nanjing 24
Des Moines 23
Lancaster 23
Florence 21
Dakar 20
Dong Ket 18
Dearborn 15
Marseille 15
Frankfurt am Main 13
Brussels 11
Nanchang 10
San Diego 10
Falls Church 9
Jacksonville 9
Hebei 8
Hong Kong 8
Izmir 8
Chicago 7
Pisa 7
Kunming 6
Rome 6
Milan 5
Aosta 4
Changsha 4
Jüchen 4
Kent 4
Munich 4
Ossé 4
San Francisco 4
Singapore 4
Tianjin 4
Toronto 4
Boulder 3
Hangzhou 3
Jeddah 3
Jiaxing 3
Jinan 3
Manchester 3
Ningbo 3
Ogden 3
Redwood City 3
Vicopisano 3
Washington 3
Abano Terme 2
Ankara 2
Bucharest 2
Canberra 2
Chengdu 2
Da Nang 2
Düsseldorf 2
Egg 2
Englewood 2
Guangzhou 2
Gurgaon 2
Hefei 2
Kocaeli 2
Los Angeles 2
New Delhi 2
Northbrook 2
Panama City 2
Phoenix 2
Queens 2
Senigallia 2
Vertemate con Minoprio 2
Ambato 1
Auburn Hills 1
Boardman 1
Central District 1
Council Bluffs 1
Diss 1
Dublin 1
Fuzhou 1
Grafing 1
Harran 1
Helsinki 1
Highland 1
Hyderabad 1
Islamabad 1
Kaohsiung 1
Totale 2.630
Nome #
Natural history of graves’ orbitopathy after treatment 165
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 155
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 148
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 146
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 139
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 136
null 121
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 114
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 112
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 110
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 108
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 107
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin 106
Thyroid volume and severity of graves' orbitopathy 104
Treatment options for Graves' orbitopathy. 100
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 98
null 97
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 96
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 95
null 93
null 91
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 91
null 88
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 86
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 83
Oxidative stress in graves' disease. 77
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 71
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 70
null 65
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 65
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 63
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 55
Selenium in Graves Hyperthyroidism and Orbitopathy 52
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 28
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 25
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 20
Total thyroid ablation in Graves' orbitopathy 7
Totale 3.387
Categoria #
all - tutte 8.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019194 0 0 0 0 0 0 0 0 0 0 99 95
2019/2020765 87 43 80 51 86 86 80 66 72 41 56 17
2020/2021286 14 19 19 30 30 10 19 29 26 31 20 39
2021/2022516 5 8 6 38 110 59 9 17 75 63 11 115
2022/2023613 64 119 54 51 46 67 6 48 118 0 37 3
2023/2024217 13 20 31 5 30 71 7 20 4 3 13 0
Totale 3.387